Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Correction: Imatinib Ameliorates Neuroinflammation in a Rat Model of Multiple Sclerosis by Enhancing Blood-Brain Barrier Integrity and by Modulating the Peripheral Immune Response.
A case of chronic inflammatory demyelinating polyneuropathy with reversible alternating diaphragmatic paralysis: case study.
Switching Therapies in Multiple Sclerosis.
High variability of fabry disease manifestations in an extended italian family.
Toll-like receptor-9 in Spanish multiple sclerosis patients: an association with the gender.
Longitudinal evaluation of cognitive functioning in pediatric multiple sclerosis: report from the US Pediatric Multiple Sclerosis Network.
Brain atrophy in natalizumab-treated patients: A 3-year follow-up.
Structures of HSF2 reveal mechanisms for differential regulation of human heat-shock factors.
A rare P2X7 variant Arg307Gln with absent pore formation function protects against neuroinflammation in multiple sclerosis.
If I had clinically isolated syndrome with magnetic resonance imaging diagnostic of multiple sclerosis, I would take vitamin D 10,000 IU daily: Yes.
Molecular epidemiology of JCV genotypes in patients and healthy subjects from Northern Italy.
Oral corticosteroids for multiple sclerosis relapse.
Interleukin-10 Gene-transfected Mature Dendritic Cells Suppress Murine Experimental Autoimmune Optic Neuritis.
Vitamin A: yet another player in multiple sclerosis pathogenesis?
Any role for probiotics in the therapy or prevention of autoimmune diseases? Up-to-date review.
New insights in the pathogenesis of multiple sclerosis-role of acrolein in neuronal and myelin damage.
Botulinum neurotoxin-A treatment of lower urinary tract symptoms in multiple sclerosis.
Single Dose of Glycoengineered Anti-CD19 Antibody (MEDI551) Disrupts Experimental Autoimmune Encephalomyelitis by Inhibiting Pathogenic Adaptive Immune Responses in the Bone Marrow and Spinal Cord While Preserving Peripheral Regulatory Mechanisms.
Contribution of CD8 T lymphocytes to the immuno-pathogenesis of multiple sclerosis and its animal models.
Sarcoidosis associated with neuromyelitis optica.
A GPBAR1 (TGR5) Small Molecule Agonist Shows Specific Inhibitory Effects on Myeloid Cell Activation In Vitro and Reduces Experimental Autoimmune Encephalitis (EAE) In Vivo.
BG-12 in Multiple Sclerosis.
Molecular interplay between T-Antigen and splicing factor, arginine/serine-rich 1 (SRSF1) controls JC virus gene expression in glial cells.
Risk for nevus transformation and melanoma proliferation and invasion during natalizumab treatment: four years of dermoscopic follow-up with immunohistological studies and proliferation and invasion assays.
Therapeutic Decisions in Multiple Sclerosis: Moving Beyond Efficacy.
Pages
« first
‹ previous
…
464
465
466
467
468
469
470
471
472
…
next ›
last »